Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000905148-18-000456
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-19 16:22:40
Reporting Period:
2018-04-17
Accepted Time:
2018-04-19 16:22:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1629151 George Henri Schuler 100 N. Field Drive
Suite 360
Lake Forest IL 60045
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Acquisiton 2018-04-17 654,136 $1.00 3,551,157 No 4 P Indirect By Tanya Eva Schuler Trust
Common Stock, Par Value $0.001 Acquisiton 2018-04-17 654,136 $1.00 3,551,157 No 4 P Indirect By Therese Heidi Schuler Trust
Common Stock, Par Value $0.001 Acquisiton 2018-04-17 145,365 $1.00 985,368 No 4 P Indirect By Schuler GC 2010 Continuation Trust
Common Stock, Par Value $0.001 Acquisiton 2018-04-17 654,137 $1.00 1,007,377 No 4 P Indirect By Schuler Grandchildren LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Tanya Eva Schuler Trust
No 4 P Indirect By Therese Heidi Schuler Trust
No 4 P Indirect By Schuler GC 2010 Continuation Trust
No 4 P Indirect By Schuler Grandchildren LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock (Right to Buy) Acquisiton 2018-04-17 2,459 $100.00 245,900 $0.00
Common Stock Series B Convertible Preferred Stock (Right to Buy) Acquisiton 2018-04-17 2,458 $100.00 245,800 $0.00
Common Stock Series B Convertible Preferred Stock (Right to Buy) Acquisiton 2018-04-17 547 $100.00 54,700 $0.00
Common Stock Series B Convertible Preferred Stock (Right to Buy) Acquisiton 2018-04-17 2,458 $100.00 245,800 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,459 No 4 P Indirect
2,458 No 4 P Indirect
547 No 4 P Indirect
2,458 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.001 141,304 Indirect By Seascape Partners L.P.
Common Stock, Par Value $0.001 26,000 Indirect By spouse
Footnotes
  1. These shares of Common Stock ("Shares") and Series B Convertible Preferred Stock ("Preferred Stock") are directly owned by the Tanya Eva Schuler Trust. H. George Schuler is the sole trustee of the Tanya Eva Schuler Trust.
  2. These Shares and Preferred Stock are directly owned by the Therese Heidi Schuler Trust. H. George Schuler is the sole trustee of the Therese Heidi Schuler Trust.
  3. These Shares and Preferred Stock are directly owned by the Schuler GC 2010 Continuation Trust. H. George Schuler is the sole trustee of the Schuler GC 2010 Continuation Trust.
  4. These Shares and Preferred Stock are directly owned by the Schuler Grandchildren LLC. H. George Schuler is the manager of the Schuler Grandchildren LLC.
  5. These Shares are directly owned by Seascape Partners L.P., a family limited partnership. H. George Schuler is the manager of Seascape Partners L.P.
  6. The reporting person disclaims beneficial ownership of these Shares and Preferred Stock except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that he is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  7. Each share of Preferred Stock is initially convertible into 100 Shares automatically upon the Requisite Stockholder Approval (defined and described further in the Schedule 13D/A filed by the Reporting Person on April 19, 2018), subject to customary anti-dilution adjustments, reflecting an initial conversion price equal to $1.00 per share. The Preferred Stock has no expiration date.